Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
13.14
0.00 (0.00%)
Aug 18, 2026, 9:58 AM EDT - Market open
Oculis Holding AG Market Cap
Oculis Holding AG has a market cap or net worth of $811.16 million as of August 18, 2026. Its market cap has decreased by -16.90% in one year.
Market Cap
811.16M
Enterprise Value
531.73M
1-Year Change
-16.90%
Ranking
Category
Stock Price
$13.14
ChartMarket Cap Chart
Since May 18, 2021, Oculis Holding AG's market cap has increased from $159.07M to $811.16M, an increase of 409.95%. That is a compound annual growth rate of 36.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 811.16M | -29.73% |
| Dec 31, 2025 | 1.15B | 61.89% |
| Dec 31, 2024 | 713.06M | 73.50% |
| Dec 29, 2023 | 411.00M | 148.15% |
| Dec 30, 2022 | 165.63M | 4.23% |
| Dec 28, 2021 | 158.90M | -0.10% |
| May 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aclaris Therapeutics | 855.96M |
| SpyGlass Pharma | 852.09M |
| Silence Therapeutics | 840.52M |
| Pharming Group | 814.40M |
| Immix Biopharma | 811.26M |
| DBV Technologies | 810.62M |
| Rigel Pharmaceuticals | 793.71M |
| Aura Biosciences | 792.30M |